PROGNOSTIC VALUE OF TUMOR MARKERS KI67 AND P53 IN DETECTING RECURRENCE OF BLADDER CANCER

Authors

  • Tillyashaykhov M.N Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, Ministry of Health of the Republic of Uzbekistan Author
  • Boyko E.V Tashkent City Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, Ministry of Health of the Republic of Uzbekistan Author
  • Yusupov Sh.Kh Tashkent City Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, Ministry of Health of the Republic of Uzbekistan. Author
  • Sullettbaev N.B Tashkent City Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, Ministry of Health of the Republic of Uzbekistan Author
  • Dyu A.V Tashkent City Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, Ministry of Health of the Republic of Uzbekistan Author

Keywords:

bladder cancer, urothelial carcinoma, immunohistochemistry

Abstract

Bladder cancer (BC) remains one of the predominant pathologies in onco-urological practice and poses a significant challenge for global healthcare. Understanding the risk factors and prognosis of this disease can improve prevention, early detection, and treatment of this type of cancer.

Downloads

Published

2024-06-22

Issue

Vol. 2 No. 6 (2024): WEJMMS

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

PROGNOSTIC VALUE OF TUMOR MARKERS KI67 AND P53 IN DETECTING RECURRENCE OF BLADDER CANCER. (2024). Western European Journal of Medicine and Medical Science, 2(6), 21-29. https://westerneuropeanstudies.com/index.php/3/article/view/1247